Literature DB >> 19605772

Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology.

Inderjit Singh1, Avtar K Singh, Miguel A Contreras.   

Abstract

The peroxisome, an ubiquitous subcellular organelle, plays an important function in cellular metabolism, and its importance for human health is underscored by the identification of fatal disorders caused by genetic abnormalities. Recent findings indicate that peroxisomal dysfunction is not only restricted to inherited peroxisomal diseases but also to disease processes associated with generation of inflammatory mediators that downregulate cellular peroxisomal homeostasis. Evidence indicates that leukodystrophies (i.e. X-linked adrenoleukodystrophy, globoid cell leukodystrophy, and periventricular leukomalacia) may share common denominators in the development and progression of the inflammatory process and thus in the dysfunctions of peroxisomes. Dysfunctions of peroxisomes may therefore contribute in part to white matter disease and to the mental and physical disabilities that develop in patients affected by these diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19605772      PMCID: PMC3077730          DOI: 10.1177/0883073809338327

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  66 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines.

Authors:  N Troffer-Charlier; N Doerflinger; E Metzger; F Fouquet; J L Mandel; P Aubourg
Journal:  Eur J Cell Biol       Date:  1998-03       Impact factor: 4.492

3.  Identification of a fourth half ABC transporter in the human peroxisomal membrane.

Authors:  N Shani; G Jimenez-Sanchez; G Steel; M Dean; D Valle
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

Review 4.  Progress in periventricular leukomalacia.

Authors:  Wenbin Deng; Jeanette Pleasure; David Pleasure
Journal:  Arch Neurol       Date:  2008-10

5.  Progressive accumulation of toxic metabolite in a genetic leukodystrophy.

Authors:  H Igisu; K Suzuki
Journal:  Science       Date:  1984-05-18       Impact factor: 47.728

6.  Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  O Lazo; M Contreras; M Hashmi; W Stanley; C Irazu; I Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.

Authors:  M Khan; K Pahan; A K Singh; I Singh
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

8.  X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.

Authors:  Esther M Maier; Peter U Mayerhofer; Muriel Asheuer; Wolfgang Köhler; Martina Rothe; Ania C Muntau; Adelbert A Roscher; Andreas Holzinger; Patrick Aubourg; Johannes Berger
Journal:  Biochem Biophys Res Commun       Date:  2008-10-01       Impact factor: 3.575

9.  Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.

Authors:  T Kobayashi; H Shinoda; I Goto; T Yamanaka; Y Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

10.  The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily.

Authors:  K Kamijo; S Taketani; S Yokota; T Osumi; T Hashimoto
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

View more
  8 in total

1.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

Review 2.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

3.  Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy.

Authors:  Leyla A Taghizadeh; Carina J King; David R Nascene; Ashish O Gupta; Paul J Orchard; LeeAnn Higgins; Todd W Markowski; Erin E Nolan; Justin W Furcich; Troy C Lund
Journal:  Sci Rep       Date:  2022-05-14       Impact factor: 4.996

4.  Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction.

Authors:  Paul L Wood; Tara Smith; Lindsay Pelzer; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-06-17       Impact factor: 3.876

5.  In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.

Authors:  Paul L Wood; M Amin Khan; Tara Smith; Greg Ehrmantraut; Wei Jin; Wei Cui; Nancy E Braverman; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-10-18       Impact factor: 3.876

Review 6.  Peroxisomes in Immune Response and Inflammation.

Authors:  Francesca Di Cara; Pierre Andreoletti; Doriane Trompier; Anne Vejux; Margret H Bülow; Julia Sellin; Gérard Lizard; Mustapha Cherkaoui-Malki; Stéphane Savary
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

7.  ATM functions at the peroxisome to induce pexophagy in response to ROS.

Authors:  Jiangwei Zhang; Durga Nand Tripathi; Ji Jing; Angela Alexander; Jinhee Kim; Reid T Powell; Ruhee Dere; Jacqueline Tait-Mulder; Ji-Hoon Lee; Tanya T Paull; Raj K Pandita; Vijaya K Charaka; Tej K Pandita; Michael B Kastan; Cheryl Lyn Walker
Journal:  Nat Cell Biol       Date:  2015-09-07       Impact factor: 28.824

Review 8.  Peroxisome Metabolism in Cancer.

Authors:  Jung-Ae Kim
Journal:  Cells       Date:  2020-07-14       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.